You are viewing the public part of the archive. Login or request access to view more content.

Displaying 13-24 of 77 results
first frame of video
00:05:09

2012_41

XIX International AIDS Conference. Interview with Gregg Alton from the Gilead Sciences, Inc. a pharmaceutical company working with health care services, policy makers, etc. to develop effective treatment, treatment as prevention and promoting access to care.

2012_41

first frame of video
00:05:56

2012_39

XIX International AIDS Conference. Interview with Shomyseh Sanjabi who is a basic Immunlogist at Gladstone Institutes. She tells about their animal model studies of HIV transmission and ageing with HIV. She is part of the CNIHR program.

2012_39

first frame of video
00:02:50

2012_38

XIX International AIDS Conference in Washington D.C. Interview with Takayuki Ota from The Scripps Research Institute in La Hoia, San Diego. He is part of the Creative and Novel Ideas in HIV Research Grants Program (CNIHR), a IAS and NIH collaboration.

2012_38

first frame of video
00:03:37

2012_37

XIX International AIDS Conference. Matias Ostrowski from University of Buenos Aires is part of the CNIHR program lead by IAS and NIH. He is involved in basic research on the cell biology of HIV with the target of creating new ideas for drug development.

2012_37

first frame of video
00:03:57

2012_36

XIX International AIDS Conference. Gretchen Neigh is a neurologist at Emory University in Atlanta working with basic research on depression. She tells about her current work on depression in HIV positive rats and her future hopes for research in humans.

2012_36

first frame of video
00:04:00

2012_35

XIX International AIDS Conference. Interview with the Immunologist Michael Elliot from University of Rochester on the CNIHR program which involves scientist not previously engaged in the HIV research field to develop new thinking withing the field.

2012_35

first frame of video
01:50:44

2012_34

XIX International AIDS Conference. Session focusing on the scientific strategies in HIV cure research, ethical questions in clinical HIV cure trials and the patient benefits of those clinical trials. The panel members are scientists and physicians, activists and long-term survivors.

2012_34

first frame of video
01:38:37

2012_31

XIX International AIDS Conference in Washington D.C. Session called "Rethinking the Role of Social Sciences in the Context of HIV/AIDS" about how theories of Social and Behavioral Sciences can be applied on HIV/AIDS in reality.

2012_31

first frame of video
01:43:46

2012_27

XIX International AIDS Conference. Session on Pediatrics with medical doctors and scientists discussing prevention of mother-to-child transmission and the development of antiretroviral treatments suitable for infants and small children.

2012_27

first frame of video
02:03:05

2012_26

XIX International AIDS Conference. Session "Gender and Science: Shifting the Paradigm in HIV Research" discussing the inclusion of structural and biological gender factors as part of HIV research, and the participation of women living with HIV in clinical trials.

2012_26

first frame of video
00:29:14

2012_23

XIX International AIDS Conference. Lecture on SAMHD1 proteins by a scientist from the French vaccine research institute ANRS. The French Minister of Higher Education and Research holds a speech about the French-American collaboration in vaccine research.

2012_23

first frame of video
00:31:21

2012_20

XIX International AIDS Conference in Washington D.C. Dr. Gottfried Hirnschall, Director of the Department of HIV and Global Hepatitis Programme of WHO, speaks at the plenary session Expanding HIV Testing and Treatment Globally.

2012_20